UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 395

Sortiert nach

The Manufacturers' Perspective on World Health Organization Prequalification of In Vitro Diagnostics

Clinical infectious diseases, 2018-01, Vol.66 (2), p.301-305

2018

Volltextzugriff (PDF)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Journal of the International AIDS Society, 2017, Vol.20 (1), p.22146-n/a

2017

Volltextzugriff (PDF)

Voluntary licensing of long‐acting HIV prevention and treatment regimens: using a proven collaboration‐ and competition‐based mechanism to rapidly expand at‐scale, sustainable, quality‐assured and affordable supplies in LMICs

Journal of the International AIDS Society, 2023-07, Vol.26 (S2), p.e26092-n/a

2023

Volltextzugriff (PDF)

Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children

The Pediatric infectious disease journal, 2022-01, Vol.41 (1), p.e1

2022

Volltextzugriff (PDF)

Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story

BMJ global health, 2023-09, Vol.8 (9), p.e012964

2023

Volltextzugriff (PDF)

Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities

The Lancet global health, 2023-01, Vol.11 (1), p.e145-e154

2023

Volltextzugriff (PDF)

relax: the analysis of biomolecular kinetics and thermodynamics using NMR relaxation dispersion data

Bioinformatics (Oxford, England), 2014-08, Vol.30 (15), p.2219-2220

2014

Volltextzugriff (PDF)

Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5

Antimicrobial agents and chemotherapy, 2014-10, Vol.58 (10), p.6215-6223

2014

Volltextzugriff (PDF)

Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly

Bioorganic & medicinal chemistry letters, 2011-01, Vol.21 (1), p.398-404

2011

Volltextzugriff (PDF)

NMR Dynamics of PSE-4 β-Lactamase: An Interplay of ps-ns Order and μs-ms Motions in the Active Site

Biophysical journal, 2009-06, Vol.96 (11), p.4681-4691

2009

Volltextzugriff (PDF)

relax: the analysis of biomolecular kinetics and thermodynamics using NMR relaxation dispersion data

Bioinformatics, 2019-10, Vol.35 (20), p.4205-4205

2019

Volltextzugriff (PDF)

Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT

PloS one, 2012-04, Vol.7 (4), p.e35074

2012

Volltextzugriff (PDF)

Structure and Dynamics of Mycobacterium tuberculosis Truncated Hemoglobin N: Insights from NMR Spectroscopy and Molecular Dynamics Simulations

Biochemistry (Easton), 2011-12, Vol.50 (51), p.11121-11130

2011

Volltextzugriff (PDF)

Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor

Journal of biomolecular NMR, 2013-01, Vol.55 (1), p.79-95

2013

Volltextzugriff (PDF)

Shortening the decade‐long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low‐ and middle‐income countries

Journal of the International AIDS Society, 2018-02, Vol.21 (S1), p.78-n/a

2018

Volltextzugriff (PDF)

Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action

The lancet HIV, 2018-05, Vol.5 (5), p.e259-e264

2018

Volltextzugriff (PDF)

Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV

ACS medicinal chemistry letters, 2014-06, Vol.5 (6), p.711-716

2014

Volltextzugriff (PDF)

Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa

BMC microbiology, 2010-10, Vol.10 (1), p.253-253, Article 253

2010

Volltextzugriff (PDF)

Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low‐ to high‐income settings: making sure no one is left behind

Journal of the International AIDS Society, 2018-04, Vol.21 (S2), p.e25060-n/a

2018

Volltextzugriff (PDF)

Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions

PloS one, 2012, Vol.7 (12), p.e52283-e52283

2012

Volltextzugriff (PDF)

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification

Bioorganic & medicinal chemistry letters, 2013-06, Vol.23 (11), p.3396-3400

2013

Volltextzugriff (PDF)

TEM-1 Backbone Dynamics—Insights from Combined Molecular Dynamics and Nuclear Magnetic Resonance

Biophysical journal, 2010-02, Vol.98 (4), p.637-645

2010

Volltextzugriff (PDF)

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure–activity relationships (SAR) of the C3-phenyl moiety

Bioorganic & medicinal chemistry letters, 2013-06, Vol.23 (11), p.3401-3405

2013

Volltextzugriff (PDF)

Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus

ACS medicinal chemistry letters, 2016-05, Vol.7 (5), p.525-530

2016

Volltextzugriff (PDF)

1 – 25 von 395

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(376)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The Manufacturers' Perspective on World Health Organization Prequalification of In Vitro Diagnostics

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Voluntary licensing of long‐acting HIV prevention and treatment regimens: using a proven collaboration‐ and competition‐based mechanism to rapidly expand at‐scale, sustainable, quality‐assured and affordable supplies in LMICs

Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children

Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story

Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV‑1

relax: the analysis of biomolecular kinetics and thermodynamics using NMR relaxation dispersion data

Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5

Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly

NMR Dynamics of PSE-4 β-Lactamase: An Interplay of ps-ns Order and μs-ms Motions in the Active Site

relax: the analysis of biomolecular kinetics and thermodynamics using NMR relaxation dispersion data

Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT

Structure and Dynamics of Mycobacterium tuberculosis Truncated Hemoglobin N: Insights from NMR Spectroscopy and Molecular Dynamics Simulations

Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor

Shortening the decade‐long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low‐ and middle‐income countries

Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action

Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV

Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa

Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low‐ to high‐income settings: making sure no one is left behind

Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification

TEM-1 Backbone Dynamics—Insights from Combined Molecular Dynamics and Nuclear Magnetic Resonance

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure–activity relationships (SAR) of the C3-phenyl moiety

Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus

Suchergebnisse filtern